Oral candidiasis of COVID-19 patients: Case report and review of evidence
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu kazuistiky, dopisy
Grantová podpora
MUNI/IGA/1543/2020
Masarykova Univerzita
LTC20031
Ministerstvo Školství, Mládeže a Tělovýchovy
PubMed
33713390
PubMed Central
PMC8251428
DOI
10.1111/jocd.14066
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, candidiasis, mouth mucosa, oral manifestations, tongue,
- MeSH
- COVID-19 * MeSH
- lidé MeSH
- orální kandidóza * farmakoterapie MeSH
- SARS-CoV-2 MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- kazuistiky MeSH
Zobrazit více v PubMed
Iranmanesh B, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID‐19 disease: a review article. Dermatol Ther. 2020;34(1):e14578. 10.1111/dth.14578 PubMed DOI PMC
Riad A, Klugar M, Krsek M. COVID‐19‐related oral manifestations: early disease features? Oral Dis. 2020. 10.1111/odi.13516 PubMed DOI PMC
Hocková B, Riad A, Valky J, et al. Oral complications of ICU patients with COVID‐19: case‐series and review of two hundred ten cases. J Clin Med. 2021;10(4):581. 10.3390/jcm10040581 PubMed DOI PMC
Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral mucosal lesions in a COVID‐19 patient: New signs or secondary manifestations? Int J Infect Dis. 2020;97:326‐328. 10.1016/j.ijid.2020.06.012 PubMed DOI PMC
Cantini F, Niccoli L, Matarrese D, Nicastri E, Stobbione P, Goletti D. Baricitinib therapy in COVID‐19: A pilot study on safety and clinical impact. J Infect. 2020;81(2):318‐356. 10.1016/j.jinf.2020.04.017 PubMed DOI PMC
Baraboutis IG, Gargalianos P, Aggelonidou E, Adraktas A. Initial real‐life experience from a designated COVID‐19 centre in Athens, Greece: a proposed therapeutic algorithm. SN Compr Clin Med. 2020;2(6):689‐693. 10.1007/s42399-020-00324-x PubMed DOI PMC
Corchuelo J, Ulloa FC. Oral manifestations in a patient with a history of asymptomatic COVID‐19: case report. Int J Infect Dis. 2020;100:154‐157. 10.1016/j.ijid.2020.08.071 PubMed DOI PMC
Díaz Rodríguez M, Jimenez Romera A, Villarroel M. Oral manifestations associated with COVID‐19. Oral Dis. 2020. 10.1111/odi.13555 PubMed DOI PMC
Dima M, Enatescu I, Craina M, Petre I, Iacob ER, Iacob D. First neonates with severe acute respiratory syndrome coronavirus 2 infection in Romania. Medicine (Baltimore). 2020;99(33):e21284. 10.1097/MD.0000000000021284 PubMed DOI PMC
Riad A, Gad A, Hockova B, Klugar M. Oral candidiasis in non‐severe COVID‐19 patients: call for antibiotic stewardship. Oral Surg. 2020. 10.1111/ors.12561 PubMed DOI PMC
Salehi M, Ahmadikia K, Mahmoudi S, et al. Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran: Species identification and antifungal susceptibility pattern. Mycoses. 2020;63(8):771‐778. 10.1111/myc.13137 PubMed DOI PMC
Fantozzi PJ, Pampena E, Di Vanna D, et al. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID‐19. Am J Otolaryngol ‐ Head Neck Med Surg. 2020;41(6):102721. 10.1016/j.amjoto.2020.102721 PubMed DOI PMC
Katz J. Prevalence of dry mouth in COVID‐19 patients with and without Sicca syndrome in a large hospital center. Irish Journal of Medical Science (1971‐). 2021;1‐3. 10.1007/s11845-020-02480-4 PubMed DOI PMC
Kottmann HE, Derman SHM, Noack MJ, Barbe AG. The underestimated problem of oral Candida colonization—An observational pilot study in one nursing home. Clin Exp Dent Res. 2019;5(6):683‐691. 10.1002/cre2.238 PubMed DOI PMC
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers
Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
